NULISA Seminar
1st April at 10:30-12:00
Onsite event
in Ministeri Lecture Hall, BioCity 1st floor
Flyer
Join us at Turku Bioscience Center for an engaging and insightful seminar where we explore how NULISA, the ultra-highly sensitive multiplexing proteomics platform from Alamar Biosciences, is revolutionizing biomarker discovery and early disease detection in oncology, inflammation, and neurodegenerative diseases. Through compelling case studies, we’ll demonstrate how NULISA enables simultaneous measurement of 120–250 proteins at attomolar sensitivity (fg/mL) using just 25 µL of sample—unlocking previously undetectable biomarkers and offering a deeper understanding of disease pathophysiology. This session will highlight how NULISA supports the entire research continuum, from translational research to clinical development, including both pre-clinical and clinical studies, all powered by the fully automated ARGO™ HT System.
Program
10:30 – 11:00 | Coffee & Registration
11:00 – 11:20 | Introduction to NULISA technology: A new ultra-highly sensitive proteomics platform for profiling low abundant fluid-based biomarker, Nikos Tertipis, Alamar Biosciences
11:20 – 11:45 | Pushing the Limits of its Sensitivity and Multiplexing: NULISA for Biomarkers Discovery and Clinical Development. Case studies, Mathias Holpert, Alamar Biosciences
11:45 – 12:00 | Q&A and closing remarks FOR
Register here: https://alamarbio.com/event/alamar-biosciences-in-turku/
Welcome everyone!
